Therapy News and Research

RSS

Acupuncture helps cut fatigue, anxiety and depression in breast cancer patients using aromatase inhibitors

Use of electroacupuncture (EA) - a form of acupuncture where a small electric current is passed between pairs of acupuncture needles - produces significant improvements in fatigue, anxiety and depression in as little as eight weeks for early stage breast cancer patients experiencing joint pain related to the use of aromatase inhibitors (AIs) to treat breast cancer.

31 Jul 2014

Telephone support program helps reduce symptoms of caregiver depression, health issues

Rhode Island Hospital researchers have found that a support program administered entirely by telephone can significantly reduce depression and other symptoms in informal caregivers, such as family or friends, of individuals with dementia.

31 Jul 2014

Post-doctoral fellows working on stem cell treatment for stroke

The San Antonio Life Sciences Institute, a joint venture between The University of Texas at San Antonio and The University of Texas Health Science Center at San Antonio, has selected the winners of the Postdoc Initiative Pilot Program.

31 Jul 2014

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).

30 Jul 2014

Scientists show for the first time how structures inside cells are regulated

New research from scientists at the University of Kent has shown for the first time how the structures inside cells are regulated - a breakthrough that could have a major impact on cancer therapy development.

30 Jul 2014

Tuberculosis in children: an interview with Dr Peter Dodd, University of Sheffield

It was recently announced that new estimates indicated over 650,000 children develop tuberculosis (TB) every year in the 22 countries with a high burden of the disease (HBCs). Which countries are these and why are so many children developing TB in these areas?

29 Jul 2014

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S.

29 Jul 2014

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues of $24.5 million for the second quarter of 2013.

From Quest Diagnostics 29 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

29 Jul 2014

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.

29 Jul 2014

First systematic analysis indicates that about 1 in 3000 donors in England have HEV

The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around 1200 HEV-containing blood components (eg, red cells, platelets, and fresh frozen plasma) are likely to be transfused every year in England.

29 Jul 2014

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA (ibrutinib) in the European Union.

29 Jul 2014

New developmental music therapy class helps babies to reach their full potential

Lisa Gracey shares a puppet of an orange bear with 11-month-old son Duke, singing 'Old MacDonald had a farm,' encouraging him to be engaged in his music therapy class. He grabs at the soft material and bounces in excitement.

29 Jul 2014

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

About 100 drugs already approved by the U.S. Food and Drug Administration (FDA) for other purposes can also prevent the growth of certain bacterial pathogens inside human cells, including those that cause Legionnaires' disease, brucellosis, and Mediterranean spotted fever.

29 Jul 2014

Cancer researchers find molecule that irreversibly interferes with KRAS gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

29 Jul 2014

Pneumococcal pneumonia mortality falling

Between 2000 and 2013 there has been an increase in the early prescription of antibiotics and use of combination therapy in patients with pneumococcal pneumonia, researchers report.

28 Jul 2014

Medicare turns up heat on fraud investigations

One U.S. attorney in South Dakota says such cases will be one of the fastest-growing areas of criminal investigations, while some providers are crying foul.

28 Jul 2014

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers.

28 Jul 2014

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Veloxis Pharmaceuticals A/S and Chiesi Farmaceutici S.p.A. today announced that the European Commission (EC) has granted marketing authorization for Envarsus for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union.

28 Jul 2014

Therapy News and Research

Acupuncture helps cut fatigue, anxiety and depression in breast cancer patients using aromatase inhibitors

Telephone support program helps reduce symptoms of caregiver depression, health issues

Post-doctoral fellows working on stem cell treatment for stroke

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

Scientists show for the first time how structures inside cells are regulated

Tuberculosis in children: an interview with Dr Peter Dodd, University of Sheffield

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

First systematic analysis indicates that about 1 in 3000 donors in England have HEV

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

New developmental music therapy class helps babies to reach their full potential

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

Cancer researchers find molecule that irreversibly interferes with KRAS gene

Pneumococcal pneumonia mortality falling

Medicare turns up heat on fraud investigations

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News